Clinical Trial Update: Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating rivoglitazone versus placebo and active comparator in patients with Type 2 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rivoglitazone (rivoglitazone)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED